Israeli company Can-Fite Biopharma, which develops and commercializes advanced clinical drugs for inflammatory and liver diseases, has raised approx. $6 million in an Initial Public Offering held on Wall Street. Next, the company is planning a public offering on the New York Stock Exchange.
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments